KALEO INC FDA Approval NDA 201739

NDA 201739

KALEO INC

FDA Drug Application

Application #201739

Documents

Label2012-08-15
Letter2012-08-14
Letter2016-05-19
Label2016-05-20
Review2012-12-04
Review2017-02-02
Letter2017-02-23
Label2017-11-17
Letter2017-11-17
Label2017-11-17
Letter2017-11-17
Pediatric Medical Review1900-01-01
Letter2019-10-01
Label2019-10-01

Application Sponsors

NDA 201739KALEO INC

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001SOLUTION;INTRAMUSCULAR, SUBCUTANEOUSEQ 0.3MG/DELIVERY1AUVI-QEPINEPHRINE
002SOLUTION;INTRAMUSCULAR, SUBCUTANEOUSEQ 0.15MG/DELIVERY1AUVI-QEPINEPHRINE
003SOLUTION;INTRAMUSCULAR, SUBCUTANEOUSEQ 0.1MG/DELIVERY1AUVI-QEPINEPHRINE

FDA Submissions

TYPE 5; Type 5 - New Formulation or New ManufacturerORIG1AP2012-08-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2014-03-22STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP2015-04-22STANDARD
LABELING; LabelingSUPPL4AP2016-05-18901 REQUIRED
UNKNOWN; SUPPL6AP2017-02-17STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2016-12-19STANDARD
EFFICACY; EfficacySUPPL8AP2017-11-17PRIORITY
LABELING; LabelingSUPPL9AP2017-11-17STANDARD
LABELING; LabelingSUPPL15AP2019-09-28STANDARD

Submissions Property Types

ORIG1Null6
SUPPL2Null0
SUPPL3Null0
SUPPL4Null15
SUPPL8Null6
SUPPL9Null7
SUPPL15Null6

TE Codes

001PrescriptionBX
002PrescriptionBX

CDER Filings

KALEO INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 201739
            [companyName] => KALEO INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"AUVI-Q","activeIngredients":"EPINEPHRINE","strength":"EQ 0.3MG\/DELIVERY","dosageForm":"SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"AUVI-Q","activeIngredients":"EPINEPHRINE","strength":"EQ 0.15MG\/DELIVERY","dosageForm":"SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"},{"drugName":"AUVI-Q","activeIngredients":"EPINEPHRINE","strength":"EQ 0.1MG\/DELIVERY","dosageForm":"SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"09\/28\/2019","submission":"SUPPL-15","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/201739s015lbl.pdf\"}]","notes":""},{"actionDate":"11\/17\/2017","submission":"SUPPL-9","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/201739s008s009lbl.pdf\"}]","notes":""},{"actionDate":"11\/17\/2017","submission":"SUPPL-8","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/201739s008s009lbl.pdf\"}]","notes":""},{"actionDate":"05\/18\/2016","submission":"SUPPL-4","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/201739s004lbl.pdf\"}]","notes":""},{"actionDate":"08\/10\/2012","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/201739s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"08\/10\/2012","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 5 - New Formulation or New Manufacturer","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/201739s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2012\\\/201739Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2012\\\/201739_auviQ_toc.cfm\"}]","notes":">"}]
            [supplements] => [{"actionDate":"09\/28\/2019","submission":"SUPPL-15","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/201739s015lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/201739Orig1s015ltr.pdf\"}]","notes":">"},{"actionDate":"11\/17\/2017","submission":"SUPPL-9","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/201739s008s009lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/201739Orig1s008,s009ltr.pdf\"}]","notes":">"},{"actionDate":"11\/17\/2017","submission":"SUPPL-8","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/201739s008s009lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/201739Orig1s008,s009ltr.pdf\"}]","notes":">"},{"actionDate":"12\/19\/2016","submission":"SUPPL-7","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"02\/17\/2017","submission":"SUPPL-6","supplementCategories":"","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/201739Orig1s006ltr.pdf\"}]","notes":"> Label is not available on this site."},{"actionDate":"05\/18\/2016","submission":"SUPPL-4","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/201739s004lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/201739Orig1s004ltr.pdf\"},{\"name\":\"Review (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2016\\\/201739Orig1s004pkg.pdf\"}]","notes":">"},{"actionDate":"04\/22\/2015","submission":"SUPPL-3","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"03\/22\/2014","submission":"SUPPL-2","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2019-09-28
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.